Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IBEX Technologies Inc V.IBT

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a... see more

TSXV:IBT - Post Discussion

IBEX Technologies Inc > Why is Ibex Shareprice holding up ??
View:
Post by guarantor1 on Apr 05, 2021 2:25pm

Why is Ibex Shareprice holding up ??

A few things (off the top of my head)

i  QI and Q2 were pretty good. And despite cautious guidance at the last year end, it looks like     Ibex will be profitable this year.

ii, Underexposed small-cap Biotech is a hot sector...and they don't come much smaller or
   underexposed than Ibex.

iii. And with that added exposure, people are looking a bit closer at Ibex's cash, P/E etc. And 
    maybe thinking it is still undervalued ?

iv Technically, IBT broke through 15 years of resistance at 30 cents. And is holding North of 30

v. Diamine Oxidase is progressing. According to Paul, it has the potential of doing $3-5M per year...and at the top end, that would mean a doubling of sales.

vi Covid is still around. And subsequent Heparin  use translates into Heparinase demand   

vii  Paul stated in the recent Youtube interview, that Ibex would certainly look at takeover offers.
     So, maybe some people are looking at Ibex as a Takeover Candidate,  

viii A lot of he shareholders have been around for a while. And most are not short term players
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities